collection
MENU ▼
Read by QxMD icon Read
search

Renal Pruritus

shared collection
50 papers 25 to 100 followers
By Isabel Acosta-Ochoa Nephrology senior staff. Valladolid. Spain
https://www.readbyqxmd.com/read/30396306/vegetarian-diet-may-ameliorate-uremic-pruritus-in-hemodialysis-patients
#1
Chun-Yang Tseng, Tai-Te Wu, Chia-Wen Lai, Hsuan-Jen Lin, Che-Yi Chou, Chiz-Tzung Chang, Hung-Chih Chen
OBJECTIVES: Systemic inflammation has been reported to be associated with uremic pruritus (UP). Although a vegetarian diet can reduce systemic inflammation in hemodialysis patients, the effect of vegetarian diet on UP is not clear. The purpose of the study was to know the possible effects of vegetarian diet on UP. METHODS: A cross-sectional study was done to compare the severity of UP and blood levels of systemic inflammatory markers between vegetarian and non-vegetarian hemodialysis patients...
November 2018: Renal Failure
https://www.readbyqxmd.com/read/30362504/itching-chloroquine-and-malaria-a-review-of-recent-molecular-and-neuroscience-advances-and-their-contribution-to-mechanistic-understanding-and-therapeutics-of-chronic-non-histaminergic-pruritus
#2
REVIEW
Adesuyi A L Ajayi
Chloroquine (CQ) is an antimalarial drug that elicits severe pruritus in black Africans with malaria fever. This acute itching (2-7 days duration) exhibits age dependency and a racial and genetic predilection. CQ itch is non-histaminergic, which makes it both a good model and a tool to probe the mechanisms of chronic itch. This review focuses on recently discovered mechanisms, neuroscience, mediators, and receptors that are implicated in molecular studies of CQ pruritus. CQ pruritus mechanisms are also compared to that of itching following other systemic diseases, such as chronic kidney disease, chronic liver disease, skin disorders, and burns...
October 26, 2018: International Journal of Dermatology
https://www.readbyqxmd.com/read/30332571/pd-1-blockade-induced-pruritus-treated-with-a-mu-opioid-receptor-antagonist
#3
LETTER
Shawn G Kwatra, Sonja Ständer, Hyunseok Kang
New England Journal of Medicine, Volume 379, Issue 16, Page 1578-1579, October 2018.
October 18, 2018: New England Journal of Medicine
https://www.readbyqxmd.com/read/30193609/-correlation-between-ameliorated-kawashima-itch-scale-and-visual-analogue-scale
#4
Zhi-Qiang Xie, Jun-Zhou Fu, Gan Chen, Chang-Jie Guan, Wen-Hu Liu, Li-Yan Wang, Moritake Sadanobu, Wenting Wu, Kawashima Makoto
Objective To preliminarily validate the clinical usability of the ameliorated Kawashima Itch Scale(Xie-Kawashima Itch Scale) among adult pruritic patients on maintenance hemodialysis. Methods Xie-Kawashima Itch Scale was developed on the basis of Kawashima Itch Scale. Patients were asked to record their pruritus condition according to Xie-Kawashima Itch Scale or visual analogue scale(VAS) during daytime and night for two weeks. The record at the second week was used for analyzing the correlation between Xie-Kawashima Itch Scale and VAS...
August 30, 2018: Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae
https://www.readbyqxmd.com/read/30141218/treatments-of-uremic-pruritus-a-systematic-review
#5
REVIEW
Leila Malekmakan, Taraneh Tadayon, Maryam Pakfetrat, Afshin Mansourian, Neda Zareei
Till now many treatments attempted to relieve uremic pruritus (UP) though none of them are definite treatment. In this study, we gathered all studies conducted on UP treatment since 2000-2016. We conducted a systematic review by searching the electronic databases (PubMed, Scopus, and Google scholar). Patients were with chronic kidney disease who complained of UP. Clinical trials and pilot studies in English and Persian which were done on patients with ESRD who complained of itching between 2000 till 2016 were gathered...
August 23, 2018: Dermatologic Therapy
https://www.readbyqxmd.com/read/30090706/role-of-narrow-band-ultra-violet-radiation-as-an-add-on-therapy-in-peritoneal-dialysis-patients-with-refractory-uremic-pruritus
#6
Ranjeeta Sapam, Rajesh Waikhom
AIM: To assess the role of narrow band ultraviolet B (UVB) as a treatment option in peritoneal dialysis patients with refractory uremic pruritus. METHODS: In this retrospective study, 29 adult patients with end stage renal failure on peritoneal dialysis, and who had refractory uremic pruritus, were given narrow band UVB radiation as an add-on therapy to standard care for a duration of 12 wk. The response to the pruritus was assessed both weekly and at the end of the study period using a visual analogue score (VAS)...
August 7, 2018: World Journal of Nephrology
https://www.readbyqxmd.com/read/30075491/a-randomized-controlled-trial-for-effectiveness-of-zolpidem-versus-acupressure-on-sleep-in-hemodialysis-patients-having-chronic-kidney-disease-associated-pruritus
#7
RANDOMIZED CONTROLLED TRIAL
Inayat Ur Rehman, David Bin-Chia Wu, Raheel Ahmed, Nisar Ahmad Khan, Aziz Ur Rahman, Syed Munib, Learn Han Lee, Kok Gan Chan, Tahir Mehmood Khan
BACKGROUND: Pruritus adds to the complications of chronic kidney disease (CKD) patient and a well-recognized complication among the CKD patients. Majority of the patients on hemodialysis experience a generalized pruritus and patients reported being moderately to extremely disturbed by at least one of the sleep-related condition. This study aim to investigate the effectiveness of zolpidem 10 mg and acupressure therapy on foot acupoints to improve the sleep quality and overall quality of life among hemodialysis patients suffering from CKD-associated pruritus...
August 2018: Medicine (Baltimore)
https://www.readbyqxmd.com/read/30065591/the-incidence-of-pruritus-and-biochemical-marker-associated-with-pruritus-in-hemodialysis-patients
#8
Soo Hyeon Noh, Kun Park, Eun Jung Kim
No abstract text is available yet for this article.
August 2018: Annals of Dermatology
https://www.readbyqxmd.com/read/30043941/pruritus-in-hemodialysis-patients-association-with-phosphorus-intake-and-serum-calcium-level
#9
Jéssica Dantas de Sá Tinôco, Maria das Graças Mariano Nunes de Paiva, Beatriz Medeiros de Macedo, Marcelly Santos Cossi, Millena Freire Delgado, Ana Luisa Brandão de Carvalho Lira
OBJECTIVE: To analyze the association between the occurrence of pruritus and adherence to the prescribed diet, biochemical indicators of renal function and the quality of hemodialysis in chronic renal patients. METHOD: A cross-sectional study performed at a dialysis clinic in the Northeast of Brazil, with 200 patients undergoing hemodialysis in the first half of 2015.To analyze the data, inferential statistics were used, using Chi-Square and Fisher's Exact tests; and Mann Whitney U test...
July 23, 2018: Revista Gaúcha de Enfermagem
https://www.readbyqxmd.com/read/30041210/current-status-and-treatment-strategies-of-hemodialysis-associated-pruritus
#10
Naoko Takahashi, Taku Yoshizawa, Shinichiro Tsuchiya
BACKGROUND: Hemodialysis-associated pruritus (HAP) is often treatment-resistant, and is a serious comorbidity that adversely affects prognosis and reduces patient quality of life through sleep disruption and depression. SUMMARY: HAP can arise from a combination of several causes; accordingly, it is often resistant to treatment. HAP patients need the specific causes of their itching to be identified, with a comprehensive approach to treatment. We have implemented our own therapeutic algorithm, which covers cause specification, for HAP since June 2009...
2018: Contributions to Nephrology
https://www.readbyqxmd.com/read/30006661/-importance-of-phototherapy-in-the-treatment-of-chronic-pruritus
#11
REVIEW
Franz J Legat
Phototherapy and photochemotherapy (PUVA) are important treatment modalities in inflammatory skin diseases such as psoriasis and atopic dermatitis as well as in cutaneous T‑cell lymphoma (e.g., mycosis fungoides/Sezary syndrome). Many of these skin diseases are accompanied by distracting pruritus. In addition, patients may suffer from intense pruritus in systemic diseases of the kidney and liver as well as of the endocrine and hematopoietic system. UV-light during phototherapy is capable of not only improving the inflammatory skin lesions but also of reducing the pruritus in skin and systemic diseases...
July 13, 2018: Der Hautarzt; Zeitschrift Für Dermatologie, Venerologie, und Verwandte Gebiete
https://www.readbyqxmd.com/read/29971209/uremic-pruritus-and-associated-factors-in-hemodialysis-patients-a-multi-center-study
#12
Nurten Ozen, Fatma Ilknur Cinar, Dilek Askin, Dilek Mut
Background: Uremic pruritus is a common and disturbing problem in hemodialysis patients. Although its pathogenesis is not completely understood, it is thought to be multifactorial. The aim of this study was to identify risk factors of uremic pruritus in hemodialysis patients. Methods: A total of 249 patients from four dialysis centers were included in this study. Data were collected using a questionnaire, the visual analogue scale, and the Hospital Anxiety and Depression Scale...
June 2018: Kidney Research and Clinical Practice
https://www.readbyqxmd.com/read/29929599/end-stage-renal-disease-chronic-itch-and-its-management
#13
REVIEW
Radomir Reszke, Jacek C Szepietowski
End-stage renal disease chronic itch is a frequent symptom that bothers patients with advanced stages of chronic kidney disease. The pathogenesis of the chronic itch symptom is complex and not yet fully understood and includes many metabolic, immunologic, and neurogenic factors. A significant burden of the disease results in decreased quality of life with sleep impairment, depressive symptoms, and increased mortality of affected individuals. No treatment of choice is available; topical therapy (emollients), phototherapy (UV-B), and systemic therapy (antiepileptics, opioid agonists, and antagonists) provide significant relief in varying percentages of patients...
July 2018: Dermatologic Clinics
https://www.readbyqxmd.com/read/29913453/uremic-pruritus-is-associated-with-two-year-cardiovascular-mortality-in-long-term-hemodialysis-patients
#14
Cheng-Hao Weng, Ching-Chih Hu, Tzung-Hai Yen, Ching-Wei Hsu, Wen-Hung Huang
BACKGROUND/AIMS: Uremic pruritus (UP) is an unpleasant complication in patients undergoing maintenance dialysis. Cardiovascular and infection related deaths are the major causes of mortality in patients undergoing dialysis. Studies on the correlation between cardiovascular or infection related mortality and UP are limited. METHODS: We analyze 866 maintenance hemodialysis (MHD) patients in our hemodialysis centers. Clinical parameters and 24-month cardiovascular and infection-related mortality are recorded...
2018: Kidney & Blood Pressure Research
https://www.readbyqxmd.com/read/29794739/prevalence-of-chronic-kidney-disease-associated-pruritus-among-adult-dialysis-patients-a-meta-analysis-of-cross-sectional-studies
#15
REVIEW
Xinmiao Hu, Yan Sang, Mei Yang, Xue Chen, Wenjuan Tang
Chronic kidney disease (CKD)-associated pruritus is a common adverse symptom in patients with end-stage renal disease treated by dialysis. Herein, a systematic review and meta-analysis of the prevalence of CKD-associated pruritus among adult dialysis patients was conducted.An electronic search of PubMed, Web of Science, Elsevier, Wanfang, and Chinese National Knowledge Infrastructure databases was conducted from inception to November 23, 2016, and all cross-sectional studies that reported the prevalence of CKD-associated pruritus in dialysis were collected...
May 2018: Medicine (Baltimore)
https://www.readbyqxmd.com/read/29778130/the-effect-of-increasing-blood-flow-rate-on-severity-of-uremic-pruritus-in-hemodialysis-patients-a-single-clinical-trial
#16
Mansooreh Aliasgharpour, Soheila Zabolypour, Ahmadali Asadinoghabi, Hamid Haghani, Mahboub Lesanpezeshki
BACKGROUND: Although the prevalence of uremic pruritus has decreased compared to the past, the problem still remains as a matter of health and a major challenge of research in medical field, and has no effective treatment at present. This study aimed to investigate the effect of increasing blood flow rate on severity of uremic pruritus in hemodialysis patients in Iran. METHODS: This clinical trial was performed on 60 hemodialysis patients that referred to hospitals affiliated to Tehran University of Medical Sciences and these patients were selected through the convenience method and were treated for four weeks...
June 2018: Journal of the National Medical Association
https://www.readbyqxmd.com/read/29391822/post-marketing-surveillance-study-of-the-safety-and-efficacy-of-nalfurafine-hydrochloride-remitch-%C3%A2-capsules-2-5-%C3%AE-g-in-3-762-hemodialysis-patients-with-intractable-pruritus
#17
Hideki Kozono, Hiroshi Yoshitani, Ryoko Nakano
Background: Intractable pruritus in hemodialysis patients can significantly decrease their quality of life and is also associated with poor vital prognosis. Although combined multiple causes of intractable pruritus in these patients have been identified, no existing treatments are proven to be sufficiently effective. We conducted a post-marketing surveillance to follow-up and assess the safety and efficacy of nalfurafine, a selective κ-opioid receptor agonist, for the treatment of intractable pruritus in patients undergoing hemodialysis...
2018: International Journal of Nephrology and Renovascular Disease
https://www.readbyqxmd.com/read/29321547/polycythemia-vera-treatment-algorithm-2018
#18
REVIEW
Ayalew Tefferi, Alessandro M Vannucchi, Tiziano Barbui
Recently reported mature survival data have confirmed the favorable prognosis in polycythemia vera (PV), with an estimated median survival of 24 years, in patients younger than age 60 years old. Currently available drugs for PV have not been shown to prolong survival or alter the natural history of the disease and are instead indicated primarily for prevention of thrombosis. Unfortunately, study endpoints that are being utilized in currently ongoing clinical trials in PV do not necessarily target clinically or biologically relevant outcomes, such as thrombosis, survival, or morphologic remission, and are instead focused on components of disease palliation...
January 10, 2018: Blood Cancer Journal
https://www.readbyqxmd.com/read/29253847/a-multicenter-randomized-double-blind-placebo-controlled-trial-of-nalbuphine-er-tablets-for-uremic-pruritus
#19
Vandana S Mathur, Jayant Kumar, Paul W Crawford, Howard Hait, Thomas Sciascia
BACKGROUND: Pruritus is a distressing hallmark of the uremic condition, affecting approximately 60% of hemodialysis patients. Abnormal endogenous opioid ligand activity at μ and κ-opioid receptors has been postulated as a mechanism in uremic pruritus. Nalbuphine is a μ-opioid antagonist and κ-opioid agonist. METHODS: In this multicenter, randomized, double-blind, placebo-controlled trial, 373 hemodialysis patients with moderate or severe uremic pruritus were randomized in a 1: 1:1 ratio to nalbuphine extended-release tablets 120 mg (NAL 120), 60 mg (NAL 60), or placebo and treated for 8 weeks...
2017: American Journal of Nephrology
https://www.readbyqxmd.com/read/29183013/uremic-pruritus-an-itch-with-ominous-consequences
#20
Michael J Germain
No abstract text is available yet for this article.
2017: American Journal of Nephrology
label_collection
label_collection
3537
1
2
2017-12-01 08:48:36
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"